China Universal Asset Management Co., Ltd. - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 130 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 1.0%.

Quarter-by-quarter ownership
China Universal Asset Management Co., Ltd. ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2
-33.3%
2,122
+96.5%
0.00%0.0%
Q2 2023$3
-40.0%
1,080
-2.9%
0.00%
-50.0%
Q1 2023$5
+25.0%
1,112
+34.0%
0.00%0.0%
Q4 2022$4
-100.0%
830
+10.4%
0.00%
-50.0%
Q3 2022$10,0007520.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Column Group LLC 18,136,735$232,513,00049.48%
Ponoi II Management, LLC 1,298,908$16,652,00045.25%
Ponoi Management, LLC 1,298,908$16,652,00026.29%
Euclidean Capital LLC 746,674$9,572,0008.14%
StepStone Group LP 1,573,357$20,170,0002.16%
First Light Asset Management, LLC 1,135,884$14,562,0001.69%
Lexington Partners L.P. 110,428$1,416,0000.73%
Rubric Capital Management LP 797,588$10,225,0000.54%
Boxer Capital, LLC 500,000$6,410,0000.41%
DAFNA Capital Management LLC 107,653$1,380,0000.38%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders